Showing 61 - 80 of 114 results
A new radiocarbon dating facility opened at the University of New South Wales (UNSW) will complement the extensive radiocarbon facilities at ANSTO’s world-leading Centre for Accelerator Science
Australian researchers and clinicians have recently returned from Japan where they investigated the use of advanced radiation therapy for cancer using heavy ions at particle therapy facilities on a study tour .
Researchers based at Monash University and the Swedish Museum of Natural History have pioneered the use of nuclear imaging techniques at ANSTO’s Centre for Neutron Scattering to resolve long-standing problems in plant evolutionary history linked to wildfires.
Congress marks watershed moment for nuclear medicine and ANSTO
Proposals at the Australian Centre for Neutron Scattering and National Deuteration Facility.
ANSTO participates in nuclear medicine congress
Guidance for obtaining and maintaining human or animal ethics approval at the Australian Synchrotron.
The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.
Commitment to undertake health research.
ANSTO shared expertise on next-generation reactors and nuclear power with sustainable energy experts at the Australian Academy of Science symposium in May.
Routine transport of spent nuclear fuel
The Medium Energy- X-ray Absorption Spectroscopy beamlines will provide access to XANES and EXAFS data from a bending magnet source, optimised for cutting-edge applications in biological, agricultural and environmental science in an energy range that is not currently available at the Australia Synchrotron.
Rare earth elements will be a key area of focus for the Australian Nuclear Science and Technology Organisation’s Minerals unit as it welcomes a $13.9 million funding allocation under the Australian Critical Minerals Research and Development Hub
A targeted radioactive infusion that is a game-changer in late-stage prostate cancer can also dramatically improve outcomes for patients in earlier stages of this disease, a Peter Mac-led study has shown.